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ABSTRACT
Replicative DNA polymerases possess 3’ ! 5’ exo-
nuclease activity to reduce misincorporation of
incorrect nucleotides by proofreading during repli-
cation. To examine if this proofreading activity mod-
ulates DNA synthesis of damaged templates, we
constructed a series of recombinant human DNA
polymerase d (Pol d) in which one or two of the
three conserved Asp residues in the exonuclease
domain are mutated, and compared their properties
with that of the wild-type enzyme. While all the
mutant enzymes lost more than 95% exonuclease
activity and severely decreased the proofreading
activity than the wild-type, the bypass efficiency of
damaged templates was varied: two mutant
enzymes, D515V and D402A/D515A, gave higher
bypass efficiencies on templates containing an
abasic site, but another mutant, D316N/D515A,
showed a lower bypass efficiency than the wild-
type. All the enzymes including the wild-type
inserted an adenine opposite the abasic site,
whereas these enzymes inserted cytosine and ade-
nine opposite an 8-oxoguanine with a ratio of 6:4.
These results indicate that the exonuclease activity
of human Pol d modulates its intrinsic bypass effi-
ciency on the damaged template, but does not
affect the choice of nucleotide to be inserted.
INTRODUCTION
Cellular DNA is constantly damaged by various endogen-
ous and exogenous agents. Many of resultant DNA
lesions can block replication. The recent discovery of a
number of DNA polymerases specialized for translesion
synthesis (TLS) has uncovered one of the general mechan-
isms to tackle the replication blocking lesions (1–4).
In a current model, when the replication fork stalls
at a damaged site, proliferating cell nuclear antigen
(PCNA) is monoubiquitinated, consequently recruiting
TLS DNA polymerase(s). Thus the stalling of the replica-
tive polymerases serves as a major trigger for PCNA ubi-
quitination and the subsequent lesion bypass by TLS
polymerases.
DNA polymerase d (Pol d) is one of the three replicative
polymerases in eukaryotes. Pol d is essential for replica-
tion and is a major enzyme for lagging-strand synthesis
(5). In mammals, it is composed of four subunits:
p125, p55, p66 and p12 (6). Pol d’s activity is strongly
stimulated by PCNA and replication factor C (RFC)
which loads PCNA onto DNA. These factors may aﬀect
lesion bypass by Pol d as suggested by Maga et al. (7).
However, since PCNA tends to slide on DNA quite freely,
stable loading of PCNA on the primer/template is critical
for evaluation of their eﬀects on Pol d’s function in vitro.
Like most other replicative DNA polymerases, Pol d
has an intrinsic 30 ! 50 exonuclease activity in its catalytic
subunit, p125. This activity participates in three distinct
ﬁdelity mechanisms: proofreading, mismatch repair and
Okazaki fragment maturation (8). In addition to these
functions on normal templates, the exonuclease activity
of replicative polymerases is anticipated to inﬂuence
DNA synthesis on damaged templates. Indeed, the exonu-
clease activities of DNA polymerases I, II and III of
Escherichia coli suppress bypass of apurinic/apyrimidinic
(AP) sites (9,10). In eukaryotes, Pol d mutants deﬁcient in
the exonuclease activity were constructed in yeast (8,11,12)
and in mice (13). While they were examined for replication
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DNA synthesis has not been reported.
To investigate the eﬀects of Pol d’s exonuclease activity
on lesion replication, we developed a bacterial expression
system for recombinant human Pol d, which allowed the
puriﬁcation of Pol d by two column chromatography
steps. This expression/puriﬁcation system for human Pol
d facilitated the screening of a number of mutant enzymes.
Using this system, we constructed exonuclease-deﬁcient
mutants. Eukaryotic Pol d enzymes share three conserved
Asp residues in the exonuclease domain with bacterioph-
age DNA polymerases in which these clustered residues
are essential for the exonuclease activity (14,15). Here, we
introduced one or two mutations into the three conserved
Asp residues of human Pol d, prepared three mutant
enzymes as well as the wild-type Pol d, and compared
their proofreading activities and translesion capabilities.
Their activities were assayed on oligonucleotide primer/
templates which were blocked at both ends with Lac
repressor proteins and a biotin/streptavidin, respectively,
to ensure stable loading of PCNA onto the DNA. Conse-
quently PCNA and its loading factor, replication factor C
(RFC), were indispensable in this assay system as for rep-
lication in vivo. Under these conditions, we examined the
Pol d’s behavior not only for stall/bypass eﬃciency but
also for error-free/error prone ratio. The nucleotide
inserted opposite the lesion was quantitatively determined
by pyrosequencing of the fully extended products.
We focused on two lesions: AP site and 8-oxoguanine
(8-OG). The AP site and 8-OG are two of the most abun-
dant lesions generated during normal cell growth (16),
so that the replication machinery must encounter these
lesions frequently. A previous study demonstrated that
AP sites strongly block yeast Pol d (17). As cited above,
however, exonuclease-mutants of some bacterial DNA
polymerases were able to bypass this lesion (9,10). In con-
trast, the 8-OG does not strongly block replication but it is
highly mutagenic and introduces a CA transversion (18).
Using our assay system, we found that, among the three
exonuclease-mutant Pol d enzymes we tested, two of
them slightly increased the bypass eﬃciency at the AP
site, while one mutant signiﬁcantly decreased the transle-
sion eﬃciency at this lesion than the wild-type enzyme.
The eﬀect of the exonuclease mutations on the bypass
eﬃciency of the 8-OG template was in the same tendency
but milder than that of the AP site template. Pyrosequenc-
ing of the bypass products revealed that the wild-type Pol
d and all the mutants inserted predominantly A opposite
the AP site, and inserted C and A opposite the 8-OG with
a 6:4 ratio. Thus the exonuclease mutations of Pol d
aﬀected the eﬃciency of lesion bypass but not the choice
of nucleotides inserted opposite lesions.
MATERIALS AND METHODS
Construction of recombinant Pol dexpression vectors
cDNAs encoding human Pol d subunits (p125, p55, p66
and p12) were obtained by RT–PCR of mRNA from
HEK293T cells with speciﬁc primers. An NdeI site and
a XhoI site were introduced into the N-terminus and
C-terminus, respectively, of each cDNA. The p125
cDNA was introduced into a pET32 (Novagen)-derived
vector in which the Lac repressor gene was deleted.
The three other cDNAs were introduced into a
pCOLADuet-1 (Novagen)-derived vector, producing
pCOLA-hPold234. In this plasmid, each cDNA was
placed under its own T7 promoter. N-terminal 16  His
and Flag tags and an N-terminal Myc tag were attached to
p12 and p66, respectively (Figure 1A). Site-directed muta-
tions shown in Figure 5A were introduced into the p125
cDNA by PCR using appropriate primers. Throughout
this study, the DNAs obtained by PCR were conﬁrmed
by sequencing to be free from undesired mutations.
Expression and purification of Pold
A host bacterial strain, BLR(DE3)(pLacRARE2), was
obtained by transformation of BLR(DE3) with a
pLacRARE2 plasmid from Rosetta2 strain (Novagen).
Human Pol d was expressed in BLR(DE3)(pLacRARE2)
cotransformed with pET-hPold1 and pCOLA-hPold234
for 12h at 168C after induction with 1mM IPTG. The
bacterial cells were harvested by centrifugation and
stored at –808C until use. The subsequent procedures
were performed at 48C. The frozen cells were suspended
in Buﬀer P-200 (40mM HEPES–NaOH, pH 7.5, 200mM
NaCl, 10% glycerol, proteinase inhibitors [Complete,
EDTA-free; Roche Diagnostics]) and lyzed with a
French Press. The supernatant was recovered after centri-
fugation at 10000r.p.m. for 10min in a JA20 rotor
(Beckman), supplemented with imidazole (ﬁnal 30mM)
and loaded onto a NiSO4-charged Chelating Sepharose
FF column (GE Healthcare) which was pre-equilibrated
with Buﬀer PI-30 (40mM HEPES–NaOH, pH 7.5,
100mM NaCl, 10% glycerol, 30mM imidazole, protei-
nase inhibitors). After sequential washing the column
with Buﬀers PI-30, P-1000 (40mM HEPES–NaOH, pH
7.5, 1M NaCl, 10% glycerol, proteinase inhibitors) and
PI-100 (40mM HEPES-NaOH, pH 7.5, 100mM NaCl,
10% glycerol, 100mM imidazole, proteinase inhibitors),
the Pol d-containing fraction was eluted with Buﬀer PI-
300 (40mM HEPES–NaOH, pH 7.5, 100mM NaCl, 10%
glycerol, 300mM imidazole, proteinase inhibitors) supple-
mented with Triton X-100 (ﬁnal 0.01%). The Ni-column
eluate was loaded onto an SP Sepharose FF column (GE
Healthcare) pre-equilibrated with Buﬀer PI-300 plus
0.01% Triton-X100. After washing the column with
Buﬀer P-200 (+0.01% Triton X-100) and Buﬀer P-500
(+0.01% Triton X-100), the Pol d-containing fraction
was eluted with Buﬀer P-1000 (+0.01% Triton X-100).
This fraction was dispensed in small aliquots and stored
at –808C. The site-directed mutant Pol ds were expressed
and puriﬁed by the same procedures as the wild-type
enzyme.
Authenticity of subunits of the puriﬁed Pol d visible by
Coomassie Blue staining was conﬁrmed by either immu-
noblotting (p125, p66, p12) or mass spectrometry (p55) as
described in ‘Results’ section. In addition, among concom-
itant bands, a band above p66 was identiﬁed as E. coli
DnaK by mass spectrometry, while several bands between
25 and 50kDa were detected with anti-p125 antibody,
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of p125.
ExpressionandpurificationofRFC,PCNAandLacrepressor
Recombinant human RFC was expressed in BLR(DE3)
(pLacRARE2) cotransformed with pET-hRfc1 and
pCOLA-hRfc2345 and puriﬁed by column chromatogra-
phy with SP Sepharose FF, Heparin Sepharose, gel ﬁltra-
tion and another SP Sepharose FF. Details of the
RFC expression vectors and puriﬁcation procedures will
be described elsewhere (manuscript in preparation).
Recombinant mouse PCNA attached with N-terminal
6xHis tag and protein kinase target site was expressed in
BL21(DE3)(pLysS) (Novagen) and puriﬁed by chroma-
tography on a NiSO4-charged Chelating Sepharose FF
column. E. coli Lac repressor protein whose C-terminal
29 residues was deleted and attached with a 6  His tag
was expressed in BL21(DE3)(pLysS) and puriﬁed by chro-
matography on a NiSO4-charged Chelating Sepharose FF
column. Since the original C-terminal domain is responsi-
ble for tetramer formation (19), the Lac repressor protein
used in this study is expected to form a homodimer but
not a tetramer.
Oligodeoxynucleotides
All the oligonucleotides used in this study were synthe-
sized by the DNA Synthesis Facility at Fox Chase
Cancer Center. Phosphoramidite derivatives for synthetic
AP site analog (dSpacer) and 8-oxodeoxyguanine were
purchased from Glen Research. The oligonucleotides
longer than 50nt were prepared by ligation of two shorter
oligonucleotides. All the oligonucleotides shown in
Figure 2 were puriﬁed by denaturing polyacrylamide gel
electrophoresis.
DNA synthesis assays
For primer extension on an oligonucleotide primer/tem-
plate, a primer indicated in each experiment (Figure 2)
was labeled with
32P at the 50 terminus and annealed
to an indicated template. This primer/template was incu-
bated with streptavidin-conjugated magnetic beads
(Streptavidin MagneSphere Paramagnetic Particles;
Promega) in the binding buﬀer (20mM HEPES–NaOH,
pH 7.5, 100mM NaCl, 10mM MgCl2) for 5min, and the
unbound primer/template was removed by washing the
magnetic beads with the binding buﬀer. A 20ml standard
reaction with 10 femtomole primer/template-bound mag-
netic beads was carried out at 378C for 30min with 200ng
PCNA, 140ng RFC, 250ng Pol d, 800ng Lac repressor in
the buﬀer containing 20mM HEPES-NaOH, pH 7.5,
100mM NaCl, 10mM MgCl2, 0.1mg/ml BSA, 0.01%
Triton X-100, 2mM ATP, 40mM each of four dNTPs.
The reaction was terminated by placing in ice/water. The
magnetic beads were washed with the binding buﬀer and
suspended in 10ml of the loading solution (95% forma-
mide, 0.5% SDS, 25mM EDTA). After boiling, the
supernatant was subjected to electrophoresis in an 8M
urea-containing 12% polyacrylamide gel.
32P-labeled reac-
tion products resolved by gel electrophoresis were visua-
lized by either autoradiography with X-ray ﬁlm or
phosphorimager, BAS-2500 (Fujiﬁlm). Quantitative anal-
yses were conducted with BAS-2500 and its ImageGauge
software.
Exonuclease assay
The ssDNA primer shown in Figure 2 was labeled with
32P at the 50 terminus, and 10 femtomole labeled oligonu-
cleotide was incubated with 37ng of indicated Pol d
enzymes at 378C for 10min in the 10ml buﬀer containing
20mM HEPES–NaOH, pH 7.5, 100mM NaCl, 10mM
MgCl2, 0.1mg/ml BSA, 0.01% Triton X-100. The reaction
was terminated by adding 20ml of the loading solution,
and the samples were analyzed by electrophoresis in an
8M urea containing 24% polyacrylamide gel followed
by scanning with phosphorimager as above. The relative
exonuclease activity was calculated by a method similar to
that of Lin et al. (20). Brieﬂy, dn, intensity of each band
corresponding to the product with n nucleotides removed
from the 30 end, was quantitated by phosphorimager.
The exonuclease activity was calculated as
P
(n dn)/ P
dn in which n=0 to 18.
Replication assaywith Xenopusegg extracts
Nucleoplasmic extract (NPE) of Xenopus laevis eggs was
prepared following the standard procedure (21). Pol d was
depleted from NPE with a rat monoclonal antibody
against the Xenopus Pol d p50 subunit. Brieﬂy, 20ml
Protein G Sepharose beads (Sigma) were precoated with
the monoclonal antibody and incubated with 40ml of NPE
and 20ml of egg lysis buﬀer (ELB: 10mM HEPES-KOH,
pH7.5, 250mM sucrose, 2.5mM MgCl2, 50mM KCl,
1mM DTT) at 48C for 2.5h. The incubation was repeated
with a fresh batch of antibody-coated beads and the
depleted extracts were saved as 5ml aliquots at –808C.
Mock depletion was carried out with Protein G
Sepharose beads only. A typical DNA synthesis reaction
contained: 5ml Pold-depleted or mock-depleted NPE,
0.5ml ATP cocktail (20mM ATP/200mM phosphocrea-
tine/0.5mg/ml creative kinase/50mM DTT), 0.25ml
32P-dATP, 0.375ml pBS—ssDNA annealed with the
ssDNA primer (Figure 2) (0.2mg/ml), and 1.375ml ELB
or recombinant Pol d (dialyzed in advance against ELB).
After incubation at room temperature for the indicated
times, the samples were treated with 0.5% SDS, 6mM
EDTA, and 1mg/ml Proteinase K at room temperature
for 2h and analyzed by 1% TAE-agarose gel electrophor-
esis. The gels were dried and analyzed for
32P incorpora-
tion by phosphorimager.
Pyrosequencing of fullyextended products
Fully extended products in Figure 6 were extracted from
the polyacrylamide gel and recovered by phenol/chloro-
form extraction and ethanol precipitation. The recovered
DNA fragments were subjected to two-step ampliﬁcations
with Advantage cDNA Polymerase Mix (Clonetech):
(i) unidirectional ampliﬁcation with a single primer com-
plementary to the extended product (25 cycles of 948C for
5s/508C for 5s/688C for 30s), and (ii) subsequent stan-
dard PCR ampliﬁcation with the second primer in addi-
tion to the ﬁrst primer (30 cycles of the same temperature
2856 Nucleic Acids Research, 2009, Vol. 37,No. 9condition). The ampliﬁed products prepared by this
method were predominantly derived from the strand
extended by Pol d, and the contribution of the template
strand was negligible. The nucleotide of interest in the
ampliﬁed products was determined by pyrosequencing
with a PSQ96MA system (Biotage) in the Biomarker
and Genotyping Facility of Fox Chase Cancer Center.
Primers used for ampliﬁcations and pyrosequencing were
summarized in Figure S1 and Table S1 of the
Supplementary Data.
Conventional sequencing of57nt G:G extended products
Fully extended products from this primer were ampliﬁed
as described above except that neither of the ampliﬁcation
primers was not biotinylated. The ampliﬁed fragments
were inserted into pCR4Blunt-TOPO (Invitrogen) and
used for transformation of TOP10 bacteria. Plasmid
DNA was prepared from individual colonies, tested by
restriction digestion for its insert. The clones carrying
the inserted fragment were subjected to DNA sequencing
with an ABI capillary genetic analyzer in the Sequencing
Facility of Fox Chase Cancer Center.
RESULTS
PreparationofrecombinanthumanPoldexpressedinbacteria
We have developed a bacterial expression system for
recombinant human Pol d in which a tag of 16 histidines
was attached at the N-terminus of p12 subunit
(Figure 1A). In preliminary experiments, we observed
that hexahistidine tagged proteins larger than 100kDa
were partially eluted from the Ni
2+-charged resin during
washing with 100mM imidazole-containing buﬀer which
still contained a signiﬁcant quantity of concomitant bac-
terial proteins (data not shown). In contrast, a majority of
His16-tagged Pol d was steadily bound to the column in
the same washing condition. Accordingly the expressed
enzyme was puriﬁed by convenient two-step procedures
with a Ni
2+-charged column and an SP Sepharose
column (Figure 1B). The SP eluate fraction contained
four polypeptides that were detected by Coomassie
staining (Figure 1B). The largest one was identiﬁed as
the catalytic subunit of Pol d by immunoblotting with
anti-p125 antibody, while the second one was a tagged
p66 by immunoblotting with anti-Myc antibody (data
not shown). The fourth subunit, p12, was detected by
immunoblotting for its attached FLAG tag. In addition,
the third polypeptide was conﬁrmed as p55 of Pol d by
mass spectrometric analysis (data not shown).
The activity of thus puriﬁed Pol d was examined
with magnetic beads-bound oligonucleotide primer/tem-
plate (Figure 3A). As shown in Figure 3B, Pol d’s activity
was stimulated with PCNA and RFC (lanes 4–6).
Furthermore, the activity increased more than two-folds
when both ends of the template were blocked, one by Lac
repressor proteins and the other by streptavidin (compare
lanes 3 and 6). This is consistent with the observation that
PCNA tends to fall oﬀ from a free end of linear DNA (22).
Together these results indicate that the bacteria-expressed
Pol d, similarly to the Pol d puriﬁed from human cells, is
stimulated by a sliding clamp, PCNA, loaded by RFC.
Recombinant Pol disactive inthe Xenopusegg extract
replication system
To further evaluate the activity of the recombinant Pol d,
we examined if it can support DNA replication in the
Xenopus nucleoplasmic extract (NPE). A singly-primed
circular pBS- ssDNA was used as the primer/template to
monitor DNA synthesis and its conversion to supercoiled
double-stranded forms. Pol d is the major polymerase
responsible for the replication of this type of substrate in
NPE. As shown in Figure 4, DNA synthesis in extracts
depleted of Pol d was drastically reduced. This defect
could largely be complemented by the addition of the
recombinant Pol d as measured by both DNA synthesis
and supercoiled product formation. These data provided
further evidence that the recombinant Pol d is fully active
in supporting the complete synthesis and maturation of
the daughter strand.
Exonuclease-deficient mutants ofPol d
Exonuclease domains of replicative DNA polymerases
have been identiﬁed from studies of bacteriophage
enzymes (14,15). These regions are well conserved even
in eukaryote enzymes including human Pol d p125
(Figure 5A). Analyses of site-directed mutations of
phage and yeast enzymes indicate that three Asp residues
in these domains are important for the exonuclease activ-
ity (8,14). Based on these data, we designed three mutants
of human Pol d: exo-1 (D515V), exo-23 (D402A/D515A)
and exo-24 (D316N/D515A). They all target the Asp resi-
dues that are involved in divalent metal bindings (23), and
conserved among DNA polymerases of organisms from
bacteriophage to mammals. The exo-1 mutation was iden-
tical to 5DV, the mutant Pol d from budding yeast that
had the lowest exonuclease activity among a series of
mutants tested by Jin et al. (8). D402/D515A for exo-23
and D316N/D515A for exo-24 were selected from muta-
tions of T4 DNA polymerase by Abdus Sattar et al. (14)
as the DNA polymerases with lowest exonuclease activ-
ities and highest polymerase activities. These mutant
enzymes were expressed and puriﬁed by the same proce-
dures as for the wild-type Pol d (Figure 1C). Their poly-
merase activities were measured by the same method
as shown in Figure 3. All three mutants retained polymer-
ase activities comparable to the wild-type (Figure 5B).
Compared to similar mutants of T4 DNA polymerases,
among which double-mutants, D219A/D324A and
D112A/D324A, lost 70% of the polymerase activity
(14), our human Pol d mutants retained the higher poly-
merase activities. Next we tested their 30 ! 50 exonuclease
activities with a 50-labeled single-stranded oligonucleotide,
and quantitated them as described by Lin et al. (20)
(Figure 5C). All mutant enzymes decreased the exonu-
clease activity by more than 95% compared to the wild-
type enzyme.
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To determine how these mutations in the exonuclease
domain aﬀect the proofreading activity of Pol d,w e
employed a series of 30-mismatched primers (Figure 2)
and examined the degradation of the primers in the
absence of dNTPs and their extensions in the presence
of dNTPs by Pol d (Figure 6). When dNTPs were omitted
from the reactions, the wild-type Pol d partially degraded
the 30 side of primers which were detected as smear pro-
ducts below the intact primers. Compared to the ssDNA
degradation shown in Figure 5C, the 30 ! 50 degradation
products of dsDNA was signiﬁcantly lesser even by the
wild-type enzyme. Nevertheless, the reactions by mutant
Pol d enzymes did not generate such smear products or, if
any, notably weaker signals than by the wild-type. This
notable diﬀerence between the wild-type and mutant
enzymes was observed with all mismatched primers
tested. When the reactions were carried out in the presence
of dNTPs, Pol d extended all the primers to full-sized
products. The extension eﬃciency was comparable
Figure 1. Expression and puriﬁcation of recombinant human Pol d.( A) Schematic structures of expression plasmids for Pol d.( B) Puriﬁcation proﬁle
of Pol d. Each fraction was electrophoresed in an SDS 4–12% polyacrylamide gel and stained with Coomassie Brilliant Blue. Lane 1, load to a Ni
2+-
Sepharose column; lane 2, ﬂow-through of the Ni
2+-Sepharose column; lane 3, a wash fraction with 1M NaCl-containing buﬀer; lane 4, a wash
fraction with 100mM imidazole-containing buﬀer; lane 5, eluate from the Ni
2+-Sepharose column with 300mM imidazole-containing buﬀer; lane 6,
ﬂow-through of an SP-Sepharose column, lane 7, a wash fraction with 200mM NaCl-containing buﬀer; lane 8, a wash fraction with 500mM NaCl-
containing buﬀer; lane 9, eluate from the SP column with 1M NaCl-containing buﬀer. (C) Puriﬁed Pol d wild-type (wt) and exonuclease mutant
enzymes. (D) Puriﬁed recombinant human RFC visualized with Coomassie staining.
Figure 2. Sequences of oligonucleotide primers and templates. 30-Terminal mispaired nucleotides in primers are underlined. Lesions in templates, 8-
OG (O) and tetrahydrofuran AP site analog (F), are also underlined. 50-Terminal biotin is indicated as B. The lac operator sequence (lacO) is
indicated by shading. Numbering of the sequence is based on the primer strand.
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extension by the exo-24 enzyme was less eﬃcient. In par-
ticular, the extension from two primers, 70nt A:A and
71nt C:C was ineﬃcient.
Although the extension eﬃciency of 30-mismatched pri-
mers by two Pol d mutants was not signiﬁcantly diﬀerent
from that of the wild-type enzyme, the proofreading activ-
ity should be directly tested by examining whether the
mismatched nucleotide was replaced with a correct
nucleotide before extension. Therefore we recovered
extended products from polyacrylamide gels shown in
Figure 6, ampliﬁed the primer-derived strand and deter-
mined what nucleotide resided at the originally mis-
matched position. For this purpose, we applied the
pyrosequencing method which can generate quantitative
sequencing data at a target position (24). Representative
raw data of this analysis are presented in Figure 7A, in
which the nucleotide sequencing of the extended product
are shown in ‘pyrogram’. In this case, following ‘ATCT’,
A and C were incorporated at the position X of the pro-
ducts extended by the wild-type Pol d with a ratio of
66%:34%, whereas the products by the exo-1 enzyme
had A and C with a ratio of 90%:10%. Since these pro-
ducts were derived from the reaction with 49nt A:G
primer/49-nt G template (Figure 2), ‘A’ corresponds
to the mispaired nucleotide, while ‘C’ corresponds to
the corrected nucleotide. All results of pyrosequencing of
30-mispaired primer extended products are summarized in
Figure 7B. It is noteworthy that the proofreading eﬃ-
ciency by the wild-type Pol d was highly variable among
diﬀerent primers tested here. With the 49nt A:G and 59nt
T:C primers, only 40% or less of the fully extended pro-
ducts were derived from the corrected primers by the wild-
type Pol d, while 80% or more of mispairs of three other
primers (63nt G:G, 70nt A:A and 71nt C:C) were cor-
rected in their fully extended products.
In the case of 57nt G:G primer, their pyrograms did not
well match to those expected from a simple mixture of the
proofread product and mispaired product (Figure S2 in
the Supplementary Data). Re-examination of the sequence
context of this primer and the template uncovered another
extension mechanism in which the looping out of 2nt in
the template can allow perfect basepairing of the 30 end
of the primer (Figure 7C). Accordingly we re-analyzed
the programs with three expected products: proofread
product, mispaired product, and product resulting from
2-nt deletion. As shown in Figure 7B, the wild-type
enzyme generated mainly the proofread product with
less quantities of the deletion product and the mispaired
product, whereas the major product by all three mutant
enzymes was the deletion product. To conﬁrm this inter-
pretation of the pyrogram data, we isolated nine clones
each from the wild-type Pol d products and the exo-1
products, and determined their structures by the conven-
tional sequencing method (Table 1). The direct sequencing
data were consistent with the pyrosequencing results,
although some minor products carrying additional muta-
tions were identiﬁed. Thus the exo- mutant enzymes were
deﬁcient in proofreading. In addition, this result indicates
Figure 3. Primer extension on an end-blocked oligonucelotide by
recombinant PCNA, RFC and Pol d.( A) Schematic structure of the
end-blocked primer/template. A biotin (B) is attached at the 50 end of
the template and is bound to a streptavidin (SA)-conjugated magnetic
bead. (B) Primer extension reactions were conducted with indicated
protein factors and the normal primer/49-nt G template as described
in ‘Materials and Methods’ section.
Figure 4. Complementation of Xenopus egg extracts with recombinant
Pol d. Single-stranded circular DNA was annealed with non-radioactive
ssDNA primer (Figure 2) and used for replication synthesis in the
presence of
32P-dATP. (A) DNA replication in Pol d- or mock-depleted
NPE. Samples taken at the indicated times were treated with SDS/
EDTA/Proteinase K and separated by 1% TAE/agarose gel electro-
phoresis. (B) Rescue of the replication defect by the recombinant Pol d.
Nucleic Acids Research,2009, Vol.37, No. 9 2859that Pol d, even the wild-type enzyme, can tolerate the
looping-out of a few nucleotides in the template.
Lesion bypass by Pol d
To evaluate the lesion bypass capability of Pol d,w e
employed oligonucleotide templates in which either an
8-OG or synthetic AP site analog was placed at a deﬁned
position (Figure 2A). By the same in vitro system as for the
proofreading analysis, the wild-type and mutant Pol d
enzymes were tested for primer extension on the templates
wherein a lesion was located at either one of two diﬀerent
positions (Figure 8). In these templates, 3nt before, and
4nt after the lesion are exactly the same, but the distance
from the primer end is diﬀerent: 8nt in 49-nt X templates
or 22nt in 63-nt X templates. In both types of templates,
the wild-type Pol d bypassed the 8-OG with 60–70% eﬃ-
ciencies (Figure 9), indicating that 8-OG caused only weak
stalling. Nucleotide-level analysis of lesion-stalled pro-
ducts indicated that Pol d primarily stopped just before
insertion of a nucleotide opposite the lesion on the 49-nt
OG template (Figure 8A, lane 7). In the case of a synthetic
AP site analog, the wild-type Pol d bypassed the lesion
with eﬃciencies of only 32% or less (Figure 9), and its
strong stalling occurred before and after a nucleotide
was inserted opposite the lesion (Figure 8A, lane 12).
When the bypass eﬃciency was compared between the
two templates, Pol d stalled at the AP site on the 63-nt
X template more strongly than on the 49-nt X template.
This is also the case with the 8-OG, although it is less
marked. Since 7nt surrounding the lesion are the same
between two sets of templates, this diﬀerence in bypass
eﬃciency seems to result from diﬀerent distances from
the primer end to the lesion, rather than the local sequence
context.
When compared to the wild-type Pol d, two mutant
enzymes, exo-1 and exo-23, increased the bypass eﬃcien-
cies at the AP site analog and slightly at the 8-OG
(Figure 9). In contrast, the exo-24 mutant signiﬁcantly
decreased the bypass eﬃciencies. These results imply that
the lesion bypass capability of Pol d does not simply cor-
relate with its exonuclease activity. On the other hand, the
direction of change of the bypass eﬃciency seems to be
speciﬁc for each mutant of Pol d but not aﬀected by lesion
type or template structure.
Nucleotide incorporatedopposite lesions by Pol d
We next determined what nucleotide was incorporated
opposite the lesions by pyrosequencing of the fully
extended products. In the experiments with the 8-OG tem-
plates, we observed that C and A were predominantly
inserted opposite the lesion (Figure 10). This is consistent
with previous studies reporting that these 2nt are most
likely to be incorporated opposite an 8-OG (18,25–28).
Figure 5. Site-directed mutants of Pol d exonuclease domains. (A)
Amino-acid sequence comparison of the exonucelase domains of repli-
cative DNA polymerases. Budding yeast and human Pol d catalytic
subunits are compared to DNA polymerases from bacterophages,
RB69 and T4. Identical residues and similar residues conserved
among the four enzymes are indicated in red and blue fonts, respec-
tively. Three aspartic acids presumed to be critical for exonuclease
activity are indicated with asterisks. Mutations introduced into
human Pol d in this study are indicated below. (B) DNA polymerase
activity with wild-type and three mutant human Pol d enzymes. The
assay was conducted with the normal primer/49-nt G templates in the
presence of PCNA, RFC and the Lac repressor as described in
‘Materials and Methods’ section. The activity was calculated as [inten-
sity of the fully extended product]/([intensity of the fully extended pro-
duct] +[intensity of the unextended primer]), and normalized with the
activity of the wild-type enzyme as 100%. Average activities and stan-
dard deviations of mutant enzymes from three experiments were
presented in the right panel. (C) Exonuclease assay of Pol d.
50-Labeled single-stranded oligonucleotide (ssDNA primer in
Figure 2) was incubated with indicated Pol d enzymes. The exonuclease
activity was calculated as described in ‘Materials and Methods’ section.
Average activities and standard deviations from three reactions were
presented in the right panel.
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6:4. Mutations in the exonuclease domain of Pol d did not
aﬀect this ratio. This result indicates that Pol d can incor-
porate C, a correct nucleotide, slightly better than A,
incorrect nucleotide, opposite the 8-OG. Nonetheless
this lesion is still mutagenic at a signiﬁcant level.
For incorporation opposite the synthetic AP site, two
rules have been proposed: the ‘A-rule’ (29) and the
‘50-rule’ (30). The ‘A-rule’ means that a number of DNA
polymerases tend to insert dAMP opposite the AP site. On
the other hand, the ‘50-rule’ model proposes that some
replicative DNA polymerases might loop out the baseless
site on the template strand and use its 50-adjacnet base to
instruct nucleotide incorporation. Thus, we tested these
two models with our template sequence, focusing on the
insertion of A and G opposite the AP site analog. In all
cases examined here, Pol d, either the wild-type or any of
the exonuclease-mutants, inserted predominantly A oppo-
site the AP site analog, while G insertion was not more
than the background level (Figure 10). It is reported that
another mechanism called ‘C-rule’ works for bypassing AP
sites in budding yeast in which C is mainly incorporated
opposite the AP site (31). However, our pyrosequencing
data clearly indicate that C was not inserted at more than
the background level. Thus the nucleotide choice of Pol d
at the AP site can be explained by the A-rule.
DISCUSSION
We report the expression, puriﬁcation and characteriza-
tion of recombinant human Pol d wild-type and exonu-
clease-mutant enzymes. Several laboratories have already
reported recombinant human Pol d prepared by various
systems. Podust et al. (32) and Xie et al. (33) indepen-
dently developed baculoviral vectors for human Pol d
expression. These systems provided high yields of the
active enzyme that may be subject to post-translational
modiﬁcations speciﬁc for eukaryotes. However, since
transfer of recombinant DNAs to baculovirus is a time-
consuming step, the baculoviral expression systems may
not be convenient for preparation of numerous mutant
enzymes. Recently, Masuda et al. (34) reported bacterial
expression and puriﬁcation of untagged human Pol d.
Their system also provided a high yield of active
enzyme, but its puriﬁcation included two column chroma-
tography steps with linear gradient elution and one size-
exclusion column step. The expression and puriﬁcation
system for human Pol d described here is less laborious
than the others and suitable for rapid screening of mutant
constructs.
The exonuclease activity of Pol d has been well studied
in yeast systems. Jin et al. (8) reported that S. cerevisiae
Pol d has a strong exonuclease activity which can comple-
tely degrade a primer annealed to a template within 10min
Figure 6. Extension of 30-mispaired primers. Reactions were conducted with indicated primers annealed to the 49-nt G template (Figure 2) in the
absence or presence of dNTPs as described in ‘Materials and Methods’ section. All the reactions contained PCNA, RFC and Lac repressor.
Nucleic Acids Research,2009, Vol.37, No. 9 2861in the absence of dNTPs. In contrast, the exonuclease
activity of S. pombe reported by Chen et al. (35) appears
to be much milder than that of S. cerevisiae. The human
Pol d described here did not extensively degrade primers
annealed to templates in the absence of dNTPs (Figure 6,
lanes with the wild-type enzyme). This seems to be consis-
tent with the relationship between humans and two yeasts
in which humans are biologically closer to S. pombe
than S. cerevisiae. To quantitatively detect the exonuclease
activity of human Pol d, we employed a single-stranded
oligonucleotide as a substrate for exonuclease assay
(Figure 5C). This assay demonstrated that the wild-type
human enzyme indeed has 30 ! 50 exonucleae activity.
Furthermore, the mutant enzymes in which the conserved
exonuclease domain was altered decreased their exonu-
clease activities by more than 95% compared to the wild
type. These results indicate that the ssDNA exonuclease
activity is derived from the conserved exonuclease domain
of human Pol d.
In spite of the apparently weak exonuclease activity on
dsDNA, the human Pol d showed signiﬁcant proofreading
activities on 30-mispaired primers (Figure 7B). In the
same assay, three exonuclease-mutant enzymes showed
constantly lower proofreading activities than the wild-
type enzyme. Nevertheless, comparison of the mispair-
extension and proofreading activities by the wild-type
and mutant enzymes on a series of 30-mispaired primer/
template combinations suggest that not only mispaired
nucleotides but also their surrounding sequences and/or
distances from the primer’s 50 terminus may aﬀect Pol
d’s behavior when encountering a 30-mispair. Using a
Figure 7. Nucleotide determination of products extended from 30-mispaired primers. (A) Representative data of pyrosequencing. The ratio of the
corrected nucleotide and the mispaired nucleotide was obtained from two peaks in the pyrogram (boxed). In this case with the 49nt A:G primer, A is
the mispaired nucleotide, while C is the corrected nucleotide opposite G. (B) Summary of pyroseqencing data. Eﬃciency of synthesis of fully
extended products over unextended primers (quantitated from Figure 6) is presented along with the ratio of proofread products (dark area) and
mispaired products (gray area). Deletion products from the 57-nt G:G primer were indicated as white area. (C) Three mechanisms for extension of
the 57-nt G:G primer. The 30-mispaired nucleotide is indicated with an asterisk.
Table 1. Analysis of 57nt G:G extension products by conventional
sequencing
Pol d Type Sequence
a Frequency
wt Proofreading ......GATCACAGCAA...... 5/9
Deletion ......GATCAGCAA...... 3/9
Other ......GATCAGCGCAA...... 1/9
exo-1 Deletion ......GATCAGCAA...... 5/9
Deletion+Mutation ......GATCGGCAA...... 1/9
Mispaired ......GATCAGAGCAA...... 1/9
Mispaired+Insertion ......GATCAGCAGCAA...... 2/9
aNucleotides resulting from proofreading, mispairing or additional
mutation are underlined.
2862 Nucleic Acids Research, 2009, Vol. 37,No. 9more simple enzyme, Bacillus stearothermophilus DNA
polymerase I large fragment, Johnson and Beese (36) ana-
lyzed all 12 possible mispairs, and accordingly categorized
into four groups of mispairs (as shown as primer
nucleotide:template nucleotide): (i) G:T, G:G, A:C, T:C
to disrupt template strand and pre-insertion site; (ii)
T:T, C:T to disrupt primer strand assembly of catalytic
site; (iii) A:G, T:G to disrupt template and primer strands;
(iv) A:A, G:A, C:C to be frayed at insertion site. However,
our results do not indicate similarity among data with
57nt G:G, 59nt T:C and 63nt G:G while data with
70nt A:A and 71nt C:C appear similar (Figure 7B).
Johnson and Beese also proposed the eﬀect of long-
range distortions caused by a mismatch up to 6nt away
from the primer end (36). Thus further analyses with a
large collection of mispaired primer/template designed
by a more systematic manner will be required to decipher
universal rules governing mispair extension and proof-
reading by DNA polymerase.
Identiﬁcation of the deletion products from the 57nt
G:G primer extension directly uncover some ﬂexibility of
human Pol d in the pocket wherein the template/primer
DNA resides. It should be noticed, however, that the
experimental condition we employed may have allowed
formation of the loop-out before the enzyme was
assembled to DNA for polymerization. Therefore it is
not clear whether the 30-mispair can be converted inside
the polymerase–DNA complex to the template loop-out.
For analyses of the proofreading activity and also for
the lesion bypass analyses, we employed pyrosequencing
to determine the nucleotide inserted into the fully
extended product at the position of interest. This
method enabled us to obtain quantitative data in a fast
and cost-eﬀective manner compared to the conventional
method which requires subcloning of the products and
subsequent sequencing of at least 20 clones. The pyrose-
quencing technique also has its own disadvantage, such as
ambiguity derived from deletion, insertion and homonu-
cleotide regions, relatively high background up to 10%.
As described for the 57nt G:G primer extension, analysis
Figure 8. Primer extension by Pol d on lesion-containing templates. (A) Extension on the 49-nt X templates. Positions of the primer end and the
lesion (X) are indicated on the right of the gel. (B) Extension on the 63-nt X templates. Both reactions were conducted in the presence of PCNA,
RFC and Lac repressor as described in ‘Materials and Methods’ section.
Figure 9. Bypass eﬃciency of Pol d on damaged templates. The eﬃ-
ciency was calculated as [intensity of the full extended product]/
([intensity of the fully extended product]+[intensity of the lesion-
stalled product]) from the data shown in Figure 8. The eﬃciency on
the normal templates was calculated with the intensity of the products
stopped at the position corresponding to the lesions.
Nucleic Acids Research,2009, Vol.37, No. 9 2863of more than two types of products may be further com-
plicated. Nevertheless, the result obtained from pyrose-
quencing was in good agreement with that from
conventional sequencing (Figure 7B, Table 1).
Translesion activity of Pol d was tested with templates
carrying either an 8-OG or AP site analog. DNA synthesis
by Pol d eﬃciently passed through the 8-OG, whereas the
AP site analog was a relatively tight blocker. Haracska et
al. (17) demonstrated that AP site cannot be bypassed by
S. cerevisiae Pol d alone. In contrast, Mozzherin et al. (37)
reported that PCNA increases AP site bypass by calf
thymus Pol d. In our system including PCNA and RFC,
human Pol d proceeded DNA synthesis through an AP
site-containing template by 20–30% eﬃciency. This
result suggests that while a majority of AP sites encoun-
tered by the replication machinery may be bypassed with
help by TLS-type DNA polymerase(s), some part of AP
site bypass can be carried out by Pol d. Recently Liao et al.
(38) characterized replication of AP site-containing DNA
by Xenopus egg extract under the condition in which the
AP site repair was suppressed. In this study, resultant rep-
lication products were classiﬁed into three groups by
nucleotides inserted opposite the AP site: (i) a nucleotide
instructed by the complementary strand (error-free pro-
ducts); (ii) dAMP regardless of the complementary
strand sequence (error-prone, A-rule); (iii) dCMP regard-
less of the complementary strand sequence (error-prone,
C-rule). The result in the present study implies that some,
if not all, of the error-prone products carrying A opposite
the AP site could result from bypass by Pol d.
It is a striking observation that one of the exonuclease-
mutant Pol d, exo-24, had a lower lesion-bypass activity
than the wild-type. This unique character of exo-24 may
be related to the severe inability to extend mispaired pri-
mers (Figure 6). The higher proofreading eﬃciency in the
products fully extended by the exo-24 enzyme compared
to the other mutants (Figure 7B) can result from its strin-
gent extension activity. One possible explanation for the
exo-24’s salient property is that this mutated exonuclease
domain may bind to the primer end more tightly than the
wild-type and other mutants, leading to ineﬃcient acces-
sibility of the primer end by the polymerase domain. Hogg
et al. (39) reported an RB69 polymerase mutant which
aﬀects active site switching, although this mutant prefer-
entially hold the primer DNA in the polymerase active
site. Our model on exo-24 could be tested by similar struc-
tural analysis.
Nucleotide preference of Pol d to insert opposite 8-OG
is the important factor in this lesion’s mutagenicity.
Shibutani et al. (18) demonstrated that calf thymus Pol d
with PCNA inserted C and A with a ratio of 1:5 opposite
8-OG. In addition, Haracska et al. (28) reported that S.
cerevisiae Pol d predominantly inserted A opposite 8-OG.
On the other hand, Maga et al. (7) reported that, when
combined with PCNA   RPA, human Pol d inserted C
and A by 3:1 ratio, suggesting that this lesion may be less
mutagenic. Our data also indicated that human Pol d
slightly preferred C insertion to A insertion at this
lesion. One possible reason for the apparent discrepancy
in these observations is that replication auxiliary proteins
may aﬀect nucleotide selection as suggested by Maga et al.
(7). Their data revealed that the addition of PCNA
reverted Pol d’s nucleotide preference from mutagenic A
to correct C. All the experimental systems discussed here
except ours employed oligonucleotides with free ends as a
primer/template and therefore PCNA may not be stably
loaded on them. In contrast, our assay system employed
end-blocked oligonucleotides, and PCNA and RFC were
essential for primer extension by Pol d in this system
(Figure 3B). Another possible reason for diﬀerent results
on 8-OG bypass is that it may due to diﬀerent lengths of
extension beyond the lesion. Most previous studies
Figure 10. Nucleotides incorporated opposite the lesions. Pyrosequencing of the fully extended products on the 63-nt X templates (Figure 8B) was
conducted as described in ‘Materials and Methods’ section. The pyrograms shown here are corresponding to the position opposite the lesions of
damaged templates or the control G nucleotide of the normal template.
2864 Nucleic Acids Research, 2009, Vol. 37,No. 9examined the nucleotide inserted opposite the lesion after
limited lengths of extension (0–5nt), whereas the reaction
products we analyzed here resulted from extension of at
least 30nt after the lesion. While studies of steady-state
kinetics on insertion and extension (7,18) can dissect the
lesion bypass reaction by DNA polymerase at a single
nucleotide level, the distorted pair of the inserted nucleo-
tide and the lesion may aﬀect the extension at relatively
distant positions as suggested with a study of mispaired
primer extensions (36). Our results seem to represent pro-
ducts preferred for long extension and simulate the natural
lesion bypass by Pol d itself. Previously we observed that
A:8-OG mispair was repaired in the replication-dependent
manner in MYH-deﬁcient mouse cells at a signiﬁcant eﬃ-
ciency although the wild-type cells repaired better (40).
Taking account of Pol d’s eﬃcient bypassing of this
lesion (Figure 9), the replication-associated repair of the
A:8-OG mispair in the absence of MYH may be explained
by the suboptimal C insertion in translesion synthesis by
Pol d in vivo, although partial contribution of TLS poly-
merases is not ruled out.
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